© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 7, 559-560,
April 2, 2003
© 2003 Oxford University Press
CORRESPONDENCE |
Re: Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: A Nested CaseControl Study Among Men
Affiliation of authors: Y.-M. Sung, N. L.-S. Tang (Department of Chemical Pathology), P. B.-S. Lai (Department of Surgery), P. K.-S. Chan (Department of Microbiology), F. K.-L. Chan (Department of Medicine and Therapeutics, Faculty of Medicine), The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Correspondence to: Nelson Leung-Sang Tang, M.D., F.R.C.P.A., Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China (e-mail: nelsontang@cuhk.edu.hk).
| The first 10% of the full text of this article appears below. |
Steroid 5
-reductase type II (SRD5A2) catalyzes the conversion of testosterone to a more potent androgen, dihydrotestosterone, and plays an important role in steroidogenesis. One hypothesis for a hormonal etiology in hepatocellular carcinoma (HCC) was raised by a study that showed a positive association between testosterone levels and
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Wang, Y. Zheng, X. Yu, W. Lin, Y. Chen, and Q. Jiang Sex-Modified Effect of Hepatitis B Virus Infection on Mortality From Primary Liver Cancer Am. J. Epidemiol., April 15, 2009; 169(8): 990 - 995. [Abstract] [Full Text] [PDF] |
||||
